全文获取类型
收费全文 | 13082篇 |
免费 | 947篇 |
国内免费 | 69篇 |
专业分类
耳鼻咽喉 | 76篇 |
儿科学 | 262篇 |
妇产科学 | 227篇 |
基础医学 | 1904篇 |
口腔科学 | 109篇 |
临床医学 | 1805篇 |
内科学 | 3242篇 |
皮肤病学 | 258篇 |
神经病学 | 1135篇 |
特种医学 | 556篇 |
外国民族医学 | 3篇 |
外科学 | 2007篇 |
综合类 | 37篇 |
一般理论 | 6篇 |
预防医学 | 580篇 |
眼科学 | 197篇 |
药学 | 861篇 |
中国医学 | 22篇 |
肿瘤学 | 811篇 |
出版年
2023年 | 84篇 |
2022年 | 132篇 |
2021年 | 401篇 |
2020年 | 221篇 |
2019年 | 333篇 |
2018年 | 396篇 |
2017年 | 275篇 |
2016年 | 282篇 |
2015年 | 366篇 |
2014年 | 501篇 |
2013年 | 640篇 |
2012年 | 1032篇 |
2011年 | 1112篇 |
2010年 | 561篇 |
2009年 | 536篇 |
2008年 | 828篇 |
2007年 | 841篇 |
2006年 | 803篇 |
2005年 | 773篇 |
2004年 | 706篇 |
2003年 | 669篇 |
2002年 | 638篇 |
2001年 | 183篇 |
2000年 | 172篇 |
1999年 | 157篇 |
1998年 | 132篇 |
1997年 | 111篇 |
1996年 | 85篇 |
1995年 | 57篇 |
1994年 | 52篇 |
1993年 | 58篇 |
1992年 | 100篇 |
1991年 | 90篇 |
1990年 | 73篇 |
1989年 | 75篇 |
1988年 | 78篇 |
1987年 | 64篇 |
1986年 | 63篇 |
1985年 | 56篇 |
1984年 | 38篇 |
1983年 | 37篇 |
1982年 | 25篇 |
1981年 | 21篇 |
1980年 | 24篇 |
1979年 | 19篇 |
1978年 | 19篇 |
1976年 | 17篇 |
1975年 | 29篇 |
1973年 | 18篇 |
1967年 | 20篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
111.
112.
113.
114.
115.
116.
David P. Al-Adra Laura Hammel John Roberts E. Steve Woodle Deborah Levine Didier Mandelbrot Elizabeth Verna Jayme Locke Jonathan D'Cunha Maryjane Farr Deirdre Sawinski Piyush K. Agarwal Jennifer Plichta Sandhya Pruthi Deborah Farr Richard Carvajal John Walker Fiona Zwald Thomas Habermann Morie Gertz Philip Bierman Don S. Dizon Carrie Langstraat Talal Al-Qaoud Scott Eggener John P. Richgels George J. Chang Cristina Geltzeiler Gonzalo Sapisochin Rocco Ricciardi Alexander S. Krupnick Cassie Kennedy Nisha Mohindra David P. Foley Kymberly D. Watt 《American journal of transplantation》2021,21(2):460-474
Patients undergoing evaluation for solid organ transplantation (SOT) often have a history of malignancy. Although the cancer has been treated in these patients, the benefits of transplantation need to be balanced against the risk of tumor recurrence, especially in the setting of immunosuppression. Prior guidelines of when to transplant patients with a prior treated malignancy do not take in to account current staging, disease biology, or advances in cancer treatments. To develop contemporary recommendations, the American Society of Transplantation held a consensus workshop to perform a comprehensive review of current literature regarding cancer therapies, cancer stage-specific prognosis, the kinetics of cancer recurrence, and the limited data on the effects of immunosuppression on cancer-specific outcomes. This document contains prognosis based on contemporary treatment and transplant recommendations for breast, colorectal, anal, urological, gynecological, and nonsmall cell lung cancers. This conference and consensus documents aim to provide recommendations to assist in the evaluation of patients for SOT given a history of a pretransplant malignancy. 相似文献
117.
Benjamin Coiffard Philipp M. Lepper Eloi Prud’Homme Florence Daviet Nadim Cassir Heinrike Wilkens Sami Hraiech Frank Langer Pascal A. Thomas Martine Reynaud-Gaubert Robert Bals Hans-Joachim Schäfers Laurent Papazian Frederik Seiler 《American journal of transplantation》2021,21(4):1586-1596
It is unknown if solid organ transplant recipients are at higher risk for severe COVID-19. The management of a lung transplantation (LTx) program and the therapeutic strategies to adapt the immunosuppressive regimen and antiviral measures is a major issue in the COVID-19 era, but little is known about worldwide practice. We sent out to 180 LTx centers worldwide in June 2020 a survey with 63 questions, both regarding the management of a LTx program in the COVID-19 era and the therapeutic strategies to treat COVID-19 LTx recipients. We received a total of 78 responses from 15 countries. Among participants, 81% declared a reduction of the activity and 47% restricted LTx for urgent cases only. Sixteen centers observed deaths on waiting listed patients and eight centers performed LTx for COVID-19 disease. In 62% of the centers, COVID-19 was diagnosed in LTx recipients, most of them not severe cases. The most common immunosuppressive management included a decreased dose or pausing of the cell cycle inhibitors. Remdesivir, hydroxychloroquine, and azithromycin were the most proposed antiviral strategies. Most of the centers have been affected by the COVID-19 pandemic and proposed an active therapeutic strategy to treat LTx recipients with COVID-19. 相似文献
118.
Christof Ernst Berberich J r me Josse Fr d ric Laurent Tristan Ferry 《World journal of orthopedics》2021,12(3):119-128
In view of the demographic changes and projected increase of arthroplasty procedures worldwide, the number of prosthetic joint infection cases will naturally grow. Therefore, in order to counteract this trend more rigid rules and a stricter implementation of effective preventive strategies is of highest importance. In the absence of a "miracle weapon" priorities should lie in evidence-based measures including preoperative optimization of patients at higher infection risks, the fulfilment of strict hygiene rules in the operating theatre and an effective antibiotic prophylaxis regimen. Instead of a "one size fits all" philosophy, it has been proposed to adjust the antibiotic prophylaxis protocol to major infection risks taking into account important patient-and procedure-related risk factors. A stronger focus on the local application mode via use of high dose dual antibioticloaded bone cement in such risk situations may have its advantages and is easy to apply in the theatre. The more potent antimicrobial growth inhibition in vitro and the strong reduction of the prosthetic joint infection rate in risk for infection patients with aid of dual antibiotic-loaded bone cement in clinical studies align with this hypothesis. 相似文献
119.